Loading patent…
AssigneeCentogene AG
InventorsMatthias Beller, Jan Lukas, Moritz Frech, Christian Junghanss, Anahit Pews-Davtyan
Estimating the term…
The present invention is related to a compound of formula (I): a pharmaceutically acceptable salt thereof, a hydrate thereof, a solvate thereof, a metabolite thereof or a prodrug thereof; for use in a method for the treatment and/or prevention of cancer, wherein X is selected from the group consisting of N—R1, O and S; R1 is selected from the group consisting of alkyl, cycloalkyl, aryl, arylalkyl and hydrogen; R2 is selected from the group consisting of indolyl, substituted indolyl, azaindolyl and substituted azaindolyl; and R3 is selected from the group consisting of aryl, substituted aryl, unsubstituted heteroaryl, heterocyclyl and substituted heterocyclyl.
A method of treatment of cancer, wherein the method comprises administering to a subject in need thereof a therapeutically effective amount of a compound having the following structure, or pharmaceutically acceptable salts thereof:
Dependencies are inferred from the claim text.